Trial Profile

An Open Label, Single Dose, Microdialysis and Pharmacokinetic Study of TR-701 [DA 7218] in Normal Healthy Adults

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 13 Dec 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tedizolid (Primary) ; Tedizolid; Tedizolid
Indications Gram-positive infections; Nosocomial pneumonia; Skin and soft tissue infections; Ventilator associated pneumonia
Focus Pharmacokinetics
Sponsors Trius Therapeutics

Most Recent Events

12 Oct 2011 Actual end date (March 2009) added as reported by ClinicalTrials.gov.
12 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
06 May 2008 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com